Global health sciences venture fund
14
25M
12
2.00
2
0.14
2
- Areas of investment
Summary
The main office of represented VC is situated in the Vancouver. The venture was found in North America in Canada.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the Global health sciences venture fund, startups are often financed by Quark Venture, Polaris Partners, NanoDimension. The meaningful sponsors for the fund in investment in the same round are Pontifax, Viva Ventures Biotech Group, Total Access Fund.
The important activity for fund was in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 20 percentage points more often commits exit comparing to other companies. The fund is constantly included in 2-6 investment rounds annually.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline SQZ Biotech, Canary Medical, ABAC Therapeutics The fund has exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. We can highlight the next thriving fund investment areas, such as Life Science, Medical.
Investments analytics
Analytics
- Total investments
- 14
- Lead investments
- 2
- Exits
- 2
- Rounds per year
- 2.00
- Follow on index
- 0.14
- Investments by industry
- Biotechnology (9)
- Health Care (8)
- Therapeutics (7)
- Medical Device (4)
- Medical (4) Show 6 more
- Investments by region
-
- United States (8)
- Canada (3)
- France (1)
- Israel (1)
- Spain (1)
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Avg. valuation at time of investment
- 916K
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| SQZ Biotech | 08 Aug 2018 | Biotechnology, Life Science, Therapeutics | Late Stage Venture | 72M | United States, Massachusetts |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.